Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells.

BioResearch open access

Peters EB, Christoforou N, Moore E, West JL, Truskey GA.
PMID: 26309784
Biores Open Access. 2015 Jan 01;4(1):75-88. doi: 10.1089/biores.2014.0029. eCollection 2015.

Mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) represent promising cell sources for angiogenic therapies. There are, however, conflicting reports regarding the ability of MSCs to support network formation of endothelial cells. The goal of this study was...

Cite
Peters EB, Christoforou N, Moore E, et al. CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. Biores Open Access. 2015;4(1):75-88doi: 10.1089/biores.2014.0029.
Peters, E. B., Christoforou, N., Moore, E., West, J. L., & Truskey, G. A. (2015). CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. BioResearch open access, 4(1), 75-88. https://doi.org/10.1089/biores.2014.0029
Peters, Erica B, et al. "CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells." BioResearch open access vol. 4,1 (2015): 75-88. doi: https://doi.org/10.1089/biores.2014.0029
Peters EB, Christoforou N, Moore E, West JL, Truskey GA. CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells. Biores Open Access. 2015 Jan 01;4(1):75-88. doi: 10.1089/biores.2014.0029. eCollection 2015. PMID: 26309784; PMCID: PMC4497669.
Copy Download .nbib Format: NLM
Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells.

Cellular and molecular bioengineering

Peters EB, Christoforou N, Leong KW, Truskey GA, West JL.
PMID: 27042236
Cell Mol Bioeng. 2016 Mar 01;9(1):38-54. doi: 10.1007/s12195-015-0423-6. Epub 2015 Oct 20.

The development of stable, functional microvessels remains an important obstacle to overcome for tissue engineered organs and treatment of ischemia. Endothelial progenitor cells (EPCs) are a promising cell source for vascular tissue engineering as they are readily obtainable and...

Cite
Peters EB, Christoforou N, Leong KW, et al. Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells. Cell Mol Bioeng. 2015;9(1):38-54doi: 10.1007/s12195-015-0423-6.
Peters, E. B., Christoforou, N., Leong, K. W., Truskey, G. A., & West, J. L. (2016). Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells. Cellular and molecular bioengineering, 9(1), 38-54. https://doi.org/10.1007/s12195-015-0423-6
Peters, Erica B, et al. "Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells." Cellular and molecular bioengineering vol. 9,1 (2016): 38-54. doi: https://doi.org/10.1007/s12195-015-0423-6
Peters EB, Christoforou N, Leong KW, Truskey GA, West JL. Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells. Cell Mol Bioeng. 2016 Mar 01;9(1):38-54. doi: 10.1007/s12195-015-0423-6. Epub 2015 Oct 20. PMID: 27042236; PMCID: PMC4812433.
Copy Download .nbib Format: NLM
The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells.

Cardiovascular engineering and technology

Cheung TM, Ganatra MP, Fu JJ, Truskey GA.
PMID: 23833691
Cardiovasc Eng Technol. 2013 Jun 01;4(2):220-230. doi: 10.1007/s13239-013-0128-8.

PURPOSE: We sought to determine the effect of stress-induced senescence on the permeability to albumin of aging endothelial progenitor cells.METHODS: Human umbilical cord blood derived endothelial cells (hCB-ECs) and human aortic endothelial cells (HAECs) were treated with 200 μM...

Cite
Cheung TM, Ganatra MP, Fu JJ, et al. The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells. Cardiovasc Eng Technol. 2013;4(2):220-230doi: 10.1007/s13239-013-0128-8.
Cheung, T. M., Ganatra, M. P., Fu, J. J., & Truskey, G. A. (2013). The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells. Cardiovascular engineering and technology, 4(2), 220-230. https://doi.org/10.1007/s13239-013-0128-8
Cheung, Tracy M, et al. "The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells." Cardiovascular engineering and technology vol. 4,2 (2013): 220-230. doi: https://doi.org/10.1007/s13239-013-0128-8
Cheung TM, Ganatra MP, Fu JJ, Truskey GA. The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells. Cardiovasc Eng Technol. 2013 Jun 01;4(2):220-230. doi: 10.1007/s13239-013-0128-8. PMID: 23833691; PMCID: PMC3698877.
Copy Download .nbib Format: NLM
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.

International journal of pharmaceutical compounding

Ben M, Trusley C, Kupiec TC, Trissel LA.
PMID: 23969774
Int J Pharm Compd. 2008 Jul-Aug;12(4):368-71.

The objective of this study was to evaluate the physical and chemical stability of undiluted palonosetron hydrochloride 50 mcg/mL when mixed with undiluted glycopyrrolate 0.2 mg/mL and neostigmine methylsulfate 0.5 mg/mL during simulated Y-site administration. Duplicate test samples were...

Cite
Ben M, Trusley C, Kupiec TC, et al. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration. Int J Pharm Compd. 2008;12(4):368-71
Ben, M., Trusley, C., Kupiec, T. C., & Trissel, L. A. (2008). Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration. International journal of pharmaceutical compounding, 12(4), 368-71.
Ben, Michel, et al. "Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration." International journal of pharmaceutical compounding vol. 12,4 (2008): 368-71.
Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration. Int J Pharm Compd. 2008 Jul-Aug;12(4):368-71. PMID: 23969774.
Copy Download .nbib Format: NLM
Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs).

Current opinion in chemical engineering

Fernandez CE, Achneck HE, Reichert WM, Truskey GA.
PMID: 24511460
Curr Opin Chem Eng. 2014 Feb 01;3:83-90. doi: 10.1016/j.coche.2013.12.001.

Considerable advances have occurred in the development of tissue-engineered blood vessels (TEBVs) to repair or replace injured blood vessels, or as

Cite
Fernandez CE, Achneck HE, Reichert WM, et al. Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs). Curr Opin Chem Eng. 2014;3:83-90doi: 10.1016/j.coche.2013.12.001.
Fernandez, C. E., Achneck, H. E., Reichert, W. M., & Truskey, G. A. (2014). Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs). Current opinion in chemical engineering, 383-90. https://doi.org/10.1016/j.coche.2013.12.001
Fernandez, Cristina E, et al. "Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs)." Current opinion in chemical engineering vol. 3 (2014): 83-90. doi: https://doi.org/10.1016/j.coche.2013.12.001
Fernandez CE, Achneck HE, Reichert WM, Truskey GA. Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs). Curr Opin Chem Eng. 2014 Feb 01;3:83-90. doi: 10.1016/j.coche.2013.12.001. PMID: 24511460; PMCID: PMC3915872.
Copy Download .nbib Format: NLM
Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness.

World journal of gastrointestinal pharmacology and therapeutics

McConnell J, Parvulescu-Codrea S, Behm B, Hill B, Dunkle E, Finke K, Snyder K, Tuskey A, Cox D, Woodward B.
PMID: 23515325
World J Gastrointest Pharmacol Ther. 2012 Oct 06;3(5):74-82. doi: 10.4292/wjgpt.v3.i5.74.

AIM: To study the safety and effectiveness associated with accelerated infliximab infusion protocols in patients with inflammatory bowel disease (IBD).METHODS: Original protocols and infusion rates were developed for the administration of infliximab over 90-min and 60-min. Then the IBD...

Cite
McConnell J, Parvulescu-Codrea S, Behm B, et al. Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness. World J Gastrointest Pharmacol Ther. 2012;3(5):74-82doi: 10.4292/wjgpt.v3.i5.74.
McConnell, J., Parvulescu-Codrea, S., Behm, B., Hill, B., Dunkle, E., Finke, K., Snyder, K., Tuskey, A., Cox, D., & Woodward, B. (2012). Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness. World journal of gastrointestinal pharmacology and therapeutics, 3(5), 74-82. https://doi.org/10.4292/wjgpt.v3.i5.74
McConnell, John, et al. "Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness." World journal of gastrointestinal pharmacology and therapeutics vol. 3,5 (2012): 74-82. doi: https://doi.org/10.4292/wjgpt.v3.i5.74
McConnell J, Parvulescu-Codrea S, Behm B, Hill B, Dunkle E, Finke K, Snyder K, Tuskey A, Cox D, Woodward B. Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness. World J Gastrointest Pharmacol Ther. 2012 Oct 06;3(5):74-82. doi: 10.4292/wjgpt.v3.i5.74. PMID: 23515325; PMCID: PMC3602441.
Copy Download .nbib Format: NLM
Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection.

Journal of clinical medicine

Islamoglu H, Cao R, Teskey G, Gyurjian K, Lucar S, Fraix MP, Sathananthan A, Chan JK, Venketaraman V.
PMID: 29494546
J Clin Med. 2018 Mar 01;7(3). doi: 10.3390/jcm7030040.

No abstract available.

Cite
Islamoglu H, Cao R, Teskey G, et al. Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection. J Clin Med. 2018;7(3)doi: 10.3390/jcm7030040.
Islamoglu, H., Cao, R., Teskey, G., Gyurjian, K., Lucar, S., Fraix, M. P., Sathananthan, A., Chan, J. K., & Venketaraman, V. (2018). Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection. Journal of clinical medicine, 7(3), . https://doi.org/10.3390/jcm7030040
Islamoglu, Hicret, et al. "Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection." Journal of clinical medicine vol. 7,3 (2018). doi: https://doi.org/10.3390/jcm7030040
Islamoglu H, Cao R, Teskey G, Gyurjian K, Lucar S, Fraix MP, Sathananthan A, Chan JK, Venketaraman V. Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection. J Clin Med. 2018 Mar 01;7(3). doi: 10.3390/jcm7030040. PMID: 29494546; PMCID: PMC5867566.
Copy Download .nbib Format: NLM
Erratum to: Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro.

Annals of biomedical engineering

Peters EB, Liu B, Christoforou N, West JL, Truskey GA.
PMID: 25877461
Ann Biomed Eng. 2015 Aug;43(8):2022. doi: 10.1007/s10439-015-1321-8.

No abstract available.

Cite
Peters EB, Liu B, Christoforou N, et al. Erratum to: Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro. Ann Biomed Eng. 2015;43(8):2022doi: 10.1007/s10439-015-1321-8.
Peters, E. B., Liu, B., Christoforou, N., West, J. L., & Truskey, G. A. (2015). Erratum to: Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro. Annals of biomedical engineering, 43(8), 2022. https://doi.org/10.1007/s10439-015-1321-8
Peters, Erica B, et al. "Erratum to: Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro." Annals of biomedical engineering vol. 43,8 (2015): 2022. doi: https://doi.org/10.1007/s10439-015-1321-8
Peters EB, Liu B, Christoforou N, West JL, Truskey GA. Erratum to: Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro. Ann Biomed Eng. 2015 Aug;43(8):2022. doi: 10.1007/s10439-015-1321-8. PMID: 25877461.
Copy Download .nbib Format: NLM
Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis.

Endoscopy international open

Brewer Gutierrez OI, Akshintala VS, Ichkhanian Y, Brewer GG, Hanada Y, Truskey MP, Agarwal A, Hajiyeva G, Kumbhari V, Kalloo AN, Khashab MA, Ngamruengphong S.
PMID: 32118105
Endosc Int Open. 2020 Mar;8(3):E313-E325. doi: 10.1055/a-1073-7593. Epub 2020 Feb 21.

No abstract available.

Cite
Brewer Gutierrez OI, Akshintala VS, Ichkhanian Y, et al. Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis. Endosc Int Open. 2020;8(3):E313-E325doi: 10.1055/a-1073-7593.
Brewer Gutierrez, O. I., Akshintala, V. S., Ichkhanian, Y., Brewer, G. G., Hanada, Y., Truskey, M. P., Agarwal, A., Hajiyeva, G., Kumbhari, V., Kalloo, A. N., Khashab, M. A., & Ngamruengphong, S. (2020). Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis. Endoscopy international open, 8(3), E313-E325. https://doi.org/10.1055/a-1073-7593
Brewer Gutierrez, Olaya I, et al. "Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis." Endoscopy international open vol. 8,3 (2020): E313-E325. doi: https://doi.org/10.1055/a-1073-7593
Brewer Gutierrez OI, Akshintala VS, Ichkhanian Y, Brewer GG, Hanada Y, Truskey MP, Agarwal A, Hajiyeva G, Kumbhari V, Kalloo AN, Khashab MA, Ngamruengphong S. Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis. Endosc Int Open. 2020 Mar;8(3):E313-E325. doi: 10.1055/a-1073-7593. Epub 2020 Feb 21. PMID: 32118105; PMCID: PMC7035039.
Copy Download .nbib Format: NLM
Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions.

APL bioengineering

Davis BN, Yen R, Prasad V, Truskey GA.
PMID: 31149650
APL Bioeng. 2019 May 15;3(2):026103. doi: 10.1063/1.5093417. eCollection 2019 Jun.

During three-dimensional culture of skeletal muscle

Cite
Davis BN, Yen R, Prasad V, et al. Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions. APL Bioeng. 2019;3(2):026103doi: 10.1063/1.5093417.
Davis, B. N., Yen, R., Prasad, V., & Truskey, G. A. (2019). Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions. APL bioengineering, 3(2), 026103. https://doi.org/10.1063/1.5093417
Davis, Brittany N, et al. "Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions." APL bioengineering vol. 3,2 (2019): 026103. doi: https://doi.org/10.1063/1.5093417
Davis BN, Yen R, Prasad V, Truskey GA. Oxygen consumption in human, tissue-engineered myobundles during basal and electrical stimulation conditions. APL Bioeng. 2019 May 15;3(2):026103. doi: 10.1063/1.5093417. eCollection 2019 Jun. PMID: 31149650; PMCID: PMC6520098.
Copy Download .nbib Format: NLM
Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model.

Transplant immunology

Watanabe T, Juvet SC, Boonstra K, Guan Z, Joe B, Teskey G, Keshavjee S, Martinu T.
PMID: 34547417
Transpl Immunol. 2021 Dec;69:101467. doi: 10.1016/j.trim.2021.101467. Epub 2021 Sep 20.

IL-17A is implicated in the pathogenesis of chronic lung allograft dysfunction, which limits survival after lung transplantation. While many cells express the IL-17 receptor A (IL-17RA) which is the main receptor for IL-17A, the cellular targets of IL-17A in...

Cite
Watanabe T, Juvet SC, Boonstra K, et al. Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model. Transpl Immunol. 2021;69:101467doi: 10.1016/j.trim.2021.101467.
Watanabe, T., Juvet, S. C., Boonstra, K., Guan, Z., Joe, B., Teskey, G., Keshavjee, S., & Martinu, T. (2021). Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model. Transplant immunology, 69101467. https://doi.org/10.1016/j.trim.2021.101467
Watanabe, Tatsuaki, et al. "Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model." Transplant immunology vol. 69 (2021): 101467. doi: https://doi.org/10.1016/j.trim.2021.101467
Watanabe T, Juvet SC, Boonstra K, Guan Z, Joe B, Teskey G, Keshavjee S, Martinu T. Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model. Transpl Immunol. 2021 Dec;69:101467. doi: 10.1016/j.trim.2021.101467. Epub 2021 Sep 20. PMID: 34547417.
Copy Download .nbib Format: NLM
In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System.

Methods in molecular biology (Clifton, N.J.)

Zhang X, Abutaleb NO, Salmon E, Truskey GA.
PMID: 34591300
Methods Mol Biol. 2022;2375:77-90. doi: 10.1007/978-1-0716-1708-3_7.

Human tissue-engineered blood vessels (TEBVs) that exhibit vasoactivity can be used to test drug toxicity, modulate pro-inflammatory cytokines, and model disease states in vitro. We developed a novel device to fabricate arteriole-scale human endothelialized TEBVs in situ with smaller...

Cite
Zhang X, Abutaleb NO, Salmon E, et al. In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System. Methods Mol Biol. 2022;2375:77-90doi: 10.1007/978-1-0716-1708-3_7.
Zhang, X., Abutaleb, N. O., Salmon, E., & Truskey, G. A. (2022). In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System. Methods in molecular biology (Clifton, N.J.), 237577-90. https://doi.org/10.1007/978-1-0716-1708-3_7
Zhang, Xu, et al. "In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System." Methods in molecular biology (Clifton, N.J.) vol. 2375 (2022): 77-90. doi: https://doi.org/10.1007/978-1-0716-1708-3_7
Zhang X, Abutaleb NO, Salmon E, Truskey GA. In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System. Methods Mol Biol. 2022;2375:77-90. doi: 10.1007/978-1-0716-1708-3_7. PMID: 34591300.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries